The Effects of Psilocybin in Major Depressive Disorder (MDD).

Major depressive disorder (MDD) is one of the most common mental health conditions affecting millions of people worldwide. Despite the availability of several conventional treatments, many MDD patients do not respond adequately to these treatments and continue to struggle with symptoms such as persistent sadness, moodiness and loss of interest in daily activities. This has led researchers to look for alternative treatments that can effectively address the symptoms of MDD. 2. Psilocybin. A promising alternative treatment is the use of psilocybin, a psychoactive substance...

The high cost and long time behind bringing a new drug to market: An inside look at pharmaceutical R&D in numbers.

The pharmaceutical industry is the industrial sector that injects the most money into the research and development (R&D) area, in 2022 alone 238 billion dollars were spent. The cost and time required for pharmaceutical research and development (R&D) can vary widely depending on the type of drug being developed and the stage of development it is in. According to a 2018 study made by the "Tufts Center for the Study of Drug Development," the average cost to develop a new drug and bring it to market is approximately $2.6 billion.